
Danny Hong
Examiner (ID: 2374, Phone: (571)270-5107 , Office: P/3727 )
| Most Active Art Unit | 3727 |
| Art Unit(s) | 3723, 3727 |
| Total Applications | 485 |
| Issued Applications | 270 |
| Pending Applications | 0 |
| Abandoned Applications | 215 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6720354
[patent_doc_number] => 20030054042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Stabilization of chemical compounds using nanoparticulate formulations'
[patent_app_type] => new
[patent_app_number] => 09/952032
[patent_app_country] => US
[patent_app_date] => 2001-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5675
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20030054042.pdf
[firstpage_image] =>[orig_patent_app_number] => 09952032
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/952032 | Stabilization of chemical compounds using nanoparticulate formulations | Sep 13, 2001 | Abandoned |
| 09/936503 | Transdermal therapeutic system and process for its production | Sep 12, 2001 | Abandoned |
Array
(
[id] => 743671
[patent_doc_number] => 07025992
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-11
[patent_title] => 'Pharmaceutical formulations'
[patent_app_type] => utility
[patent_app_number] => 09/951022
[patent_app_country] => US
[patent_app_date] => 2001-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 16690
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/025/07025992.pdf
[firstpage_image] =>[orig_patent_app_number] => 09951022
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/951022 | Pharmaceutical formulations | Sep 11, 2001 | Issued |
Array
(
[id] => 6356936
[patent_doc_number] => 20020058063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'Stable pharmaceutical dosage form for paroxetin anhydrate'
[patent_app_type] => new
[patent_app_number] => 09/949899
[patent_app_country] => US
[patent_app_date] => 2001-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 795
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20020058063.pdf
[firstpage_image] =>[orig_patent_app_number] => 09949899
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/949899 | Stable pharmaceutical dosage form for paroxetin anhydrate | Sep 11, 2001 | Issued |
Array
(
[id] => 1373799
[patent_doc_number] => 06555119
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-29
[patent_title] => 'Transparent micro emulsion'
[patent_app_type] => B1
[patent_app_number] => 09/936406
[patent_app_country] => US
[patent_app_date] => 2001-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6477
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/555/06555119.pdf
[firstpage_image] =>[orig_patent_app_number] => 09936406
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/936406 | Transparent micro emulsion | Sep 10, 2001 | Issued |
Array
(
[id] => 1285490
[patent_doc_number] => 06635254
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-10-21
[patent_title] => 'Surface modification of lamellar particles'
[patent_app_type] => B2
[patent_app_number] => 09/948319
[patent_app_country] => US
[patent_app_date] => 2001-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6036
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/635/06635254.pdf
[firstpage_image] =>[orig_patent_app_number] => 09948319
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/948319 | Surface modification of lamellar particles | Sep 5, 2001 | Issued |
Array
(
[id] => 1527496
[patent_doc_number] => 06479060
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-12
[patent_title] => 'Elegant hydrogenated castor oil ointments'
[patent_app_type] => B1
[patent_app_number] => 09/945903
[patent_app_country] => US
[patent_app_date] => 2001-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2398
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/479/06479060.pdf
[firstpage_image] =>[orig_patent_app_number] => 09945903
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/945903 | Elegant hydrogenated castor oil ointments | Sep 3, 2001 | Issued |
Array
(
[id] => 6079957
[patent_doc_number] => 20020081332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Controlled release formulation of erythromycin or a derivative thereof'
[patent_app_type] => new
[patent_app_number] => 09/941970
[patent_app_country] => US
[patent_app_date] => 2001-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3092
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20020081332.pdf
[firstpage_image] =>[orig_patent_app_number] => 09941970
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/941970 | Controlled release formulation of erythromycin or a derivative thereof | Aug 28, 2001 | Abandoned |
Array
(
[id] => 1245161
[patent_doc_number] => 06676960
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-01-13
[patent_title] => 'Intraoral adhesive preparation'
[patent_app_type] => B2
[patent_app_number] => 09/940946
[patent_app_country] => US
[patent_app_date] => 2001-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8600
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/676/06676960.pdf
[firstpage_image] =>[orig_patent_app_number] => 09940946
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/940946 | Intraoral adhesive preparation | Aug 27, 2001 | Issued |
Array
(
[id] => 1268649
[patent_doc_number] => 06652865
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-11-25
[patent_title] => 'Method and formulation for decreasing statin metabolism'
[patent_app_type] => B2
[patent_app_number] => 09/935277
[patent_app_country] => US
[patent_app_date] => 2001-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3821
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/652/06652865.pdf
[firstpage_image] =>[orig_patent_app_number] => 09935277
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/935277 | Method and formulation for decreasing statin metabolism | Aug 21, 2001 | Issued |
Array
(
[id] => 6749942
[patent_doc_number] => 20030044462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Sustained release tablets containing bupropion hydrochloride'
[patent_app_type] => new
[patent_app_number] => 09/933559
[patent_app_country] => US
[patent_app_date] => 2001-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1726
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20030044462.pdf
[firstpage_image] =>[orig_patent_app_number] => 09933559
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/933559 | Sustained release tablets containing bupropion hydrochloride | Aug 19, 2001 | Abandoned |
Array
(
[id] => 1265577
[patent_doc_number] => 06656494
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-02
[patent_title] => 'Method of feeding reproductive female pigs and feeds for reproductive female pigs'
[patent_app_type] => B1
[patent_app_number] => 09/913739
[patent_app_country] => US
[patent_app_date] => 2001-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8810
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/656/06656494.pdf
[firstpage_image] =>[orig_patent_app_number] => 09913739
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/913739 | Method of feeding reproductive female pigs and feeds for reproductive female pigs | Aug 16, 2001 | Issued |
Array
(
[id] => 1324687
[patent_doc_number] => 06599526
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-07-29
[patent_title] => 'Pericardial anti-adhesion patch'
[patent_app_type] => B2
[patent_app_number] => 09/932617
[patent_app_country] => US
[patent_app_date] => 2001-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 26
[patent_no_of_words] => 9648
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/599/06599526.pdf
[firstpage_image] =>[orig_patent_app_number] => 09932617
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/932617 | Pericardial anti-adhesion patch | Aug 16, 2001 | Issued |
Array
(
[id] => 344856
[patent_doc_number] => 07498042
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-03
[patent_title] => 'Stent for blood vessel and material for stent for blood vessel'
[patent_app_type] => utility
[patent_app_number] => 10/182271
[patent_app_country] => US
[patent_app_date] => 2001-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 11
[patent_no_of_words] => 6128
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/498/07498042.pdf
[firstpage_image] =>[orig_patent_app_number] => 10182271
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/182271 | Stent for blood vessel and material for stent for blood vessel | Aug 7, 2001 | Issued |
Array
(
[id] => 1295511
[patent_doc_number] => 06627206
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-09-30
[patent_title] => 'Method and apparatus for treating obesity and for delivering time-released medicaments'
[patent_app_type] => B2
[patent_app_number] => 09/916038
[patent_app_country] => US
[patent_app_date] => 2001-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 5212
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/627/06627206.pdf
[firstpage_image] =>[orig_patent_app_number] => 09916038
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/916038 | Method and apparatus for treating obesity and for delivering time-released medicaments | Jul 24, 2001 | Issued |
| 09/830056 | Gelatins with low allergenicity | Jul 23, 2001 | Abandoned |
Array
(
[id] => 6791622
[patent_doc_number] => 20030086966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Antihistamine formulations for soft gelatin dosage forms'
[patent_app_type] => new
[patent_app_number] => 09/909313
[patent_app_country] => US
[patent_app_date] => 2001-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4232
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20030086966.pdf
[firstpage_image] =>[orig_patent_app_number] => 09909313
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/909313 | Antihistamine formulations for soft capsule dosage forms | Jul 19, 2001 | Issued |
| 09/831649 | Pharmaceutical composition for modified release insulin sensitiser | Jul 18, 2001 | Abandoned |
Array
(
[id] => 6131694
[patent_doc_number] => 20020077364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'Thyroid hormone formulations'
[patent_app_type] => new
[patent_app_number] => 09/900094
[patent_app_country] => US
[patent_app_date] => 2001-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5778
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20020077364.pdf
[firstpage_image] =>[orig_patent_app_number] => 09900094
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/900094 | Thyroid hormone formulations | Jul 5, 2001 | Abandoned |
Array
(
[id] => 7545028
[patent_doc_number] => 08052998
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-08
[patent_title] => 'Particulate vectors for improving oral absorption of active principles'
[patent_app_type] => utility
[patent_app_number] => 10/332351
[patent_app_country] => US
[patent_app_date] => 2001-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5155
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/052/08052998.pdf
[firstpage_image] =>[orig_patent_app_number] => 10332351
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/332351 | Particulate vectors for improving oral absorption of active principles | Jul 4, 2001 | Issued |